Bluestein R H & Co. Sells 2,000 Shares of Xylem Inc (XYL)

Bluestein R H & Co. trimmed its stake in shares of Xylem Inc (NYSE:XYL) by 25.6% during the 1st quarter, Holdings Channel reports. The fund owned 5,800 shares of the industrial products company’s stock after selling 2,000 shares during the quarter. Bluestein R H & Co.’s holdings in Xylem were worth $458,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently bought and sold shares of the company. Sandy Spring Bank grew its position in shares of Xylem by 101.2% in the 1st quarter. Sandy Spring Bank now owns 338 shares of the industrial products company’s stock worth $27,000 after buying an additional 170 shares during the last quarter. Cullen Frost Bankers Inc. bought a new stake in shares of Xylem in the 1st quarter worth approximately $28,000. Liberty Wealth Management LLC bought a new stake in shares of Xylem in the 4th quarter worth approximately $35,000. Doyle Wealth Management bought a new stake in shares of Xylem in the 4th quarter worth approximately $36,000. Finally, CWM LLC grew its position in shares of Xylem by 100.9% in the 4th quarter. CWM LLC now owns 681 shares of the industrial products company’s stock worth $45,000 after buying an additional 342 shares during the last quarter. Institutional investors and hedge funds own 86.94% of the company’s stock.

XYL has been the topic of a number of recent analyst reports. Janney Montgomery Scott upgraded Xylem from a “neutral” rating to a “buy” rating and set a $86.00 price objective on the stock in a research report on Friday, May 3rd. ValuEngine lowered Xylem from a “buy” rating to a “hold” rating in a research report on Tuesday. Zacks Investment Research lowered Xylem from a “hold” rating to a “sell” rating in a research report on Friday, April 5th. BMO Capital Markets reiterated a “buy” rating and issued a $85.00 price objective on shares of Xylem in a research report on Monday, February 25th. Finally, Stifel Nicolaus lowered their target price on Xylem from $93.00 to $89.00 and set a “buy” rating for the company in a research note on Friday, May 3rd. One equities research analyst has rated the stock with a sell rating, six have given a hold rating and nine have issued a buy rating to the company. Xylem currently has an average rating of “Buy” and a consensus price target of $78.93.



In other Xylem news, SVP Pak Steven Leung sold 8,947 shares of Xylem stock in a transaction on Friday, May 10th. The stock was sold at an average price of $78.55, for a total transaction of $702,786.85. Following the completion of the transaction, the senior vice president now owns 42,980 shares in the company, valued at $3,376,079. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Steven R. Loranger sold 10,000 shares of Xylem stock in a transaction on Friday, March 15th. The shares were sold at an average price of $76.99, for a total value of $769,900.00. Following the transaction, the director now owns 26,744 shares of the company’s stock, valued at approximately $2,059,020.56. The disclosure for this sale can be found here. Insiders have sold 68,460 shares of company stock valued at $5,403,327 in the last quarter. 0.85% of the stock is owned by company insiders.

Shares of NYSE:XYL opened at $75.51 on Wednesday. The firm has a market cap of $13.82 billion, a price-to-earnings ratio of 26.22, a P/E/G ratio of 1.44 and a beta of 1.15. Xylem Inc has a 12-month low of $60.65 and a 12-month high of $84.41. The company has a debt-to-equity ratio of 0.73, a current ratio of 1.44 and a quick ratio of 1.02.

Xylem (NYSE:XYL) last announced its quarterly earnings data on Thursday, May 2nd. The industrial products company reported $0.52 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $0.58 by ($0.06). The company had revenue of $1.24 billion for the quarter, compared to analysts’ expectations of $1.25 billion. Xylem had a net margin of 10.50% and a return on equity of 19.46%. The firm’s quarterly revenue was up 1.6% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.51 EPS. As a group, research analysts anticipate that Xylem Inc will post 3.24 EPS for the current year.

COPYRIGHT VIOLATION WARNING: This piece was published by Dakota Financial News and is owned by of Dakota Financial News. If you are viewing this piece on another website, it was illegally copied and reposted in violation of United States and international copyright & trademark laws. The original version of this piece can be accessed at https://dakotafinancialnews.com/2019/05/15/bluestein-r-h-co-sells-2000-shares-of-xylem-inc-xyl.html.

About Xylem

Xylem Inc engages in the design, manufacture, and servicing of engineered products and solutions for the water and wastewater applications. It operates in three segments: Water Infrastructure, Applied Water, and Measurement & Control Solutions. The Water Infrastructure segment offers various products, including water and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment under the Flygt, Godwin, Wedeco, Sanitaire, and Leopold names for the transportation and treatment of water.

Featured Story: Channel Trading

Want to see what other hedge funds are holding XYL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Xylem Inc (NYSE:XYL).

Institutional Ownership by Quarter for Xylem (NYSE:XYL)

Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.